Balanced news tone
News Sentiment
NOVN sentiment intelligence
Novartis AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-2.8% over one week, +1.8% over four weeks, trend active, and materially above fair value.
Is Novartis (SWX:NOVN) Undervalued As EU Expands Approval For Its Gene Therapy?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Is Novartis (SWX:NOVN) Undervalued As EU Expands Approval For Its Gene Therapy?
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 17 Jul 2026 05:45
- Source
- simplywall.st
Novartis stock holds steady on its global drug pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 18:14
- Source
- ad-hoc-news.de
Novartis stock. Generalized update on the Swiss drugmaker.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 05:05
- Source
- ad-hoc-news.de
Novartis (SWX:NOVN) Stock Looks Cheap on Value But Pricey After 93% Return
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
Novartis (SWX:NOVN) Wins EU Approval For Itvisma In A Broader SMA Market
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 03 Jul 2026 07:00
- Source
- Market source
Novartis AG (NVS) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 82/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:34
- Source
- GuruFocus
Is Novartis (SWX:NOVN) Fully Valued On Its Pipeline And Margin Growth Story?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Jun 2026 07:00
- Source
- simplywall.st
Novartis AG (NVS): 7 Best Longevity and Anti-Aging Stocks to Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Novartis AG Stock (CH0012005267): Analyst Targets and SMI Role Keep Shares in Focus
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jun 2026 07:00
- Source
- ad-hoc-news.de
Novartis AG Stock (CH0012005267): In focus on a quiet Sunday session
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- ad-hoc-news.de
Assessing Novartis (SWX:NOVN) Valuation After A Strong Year Of Total Shareholder Returns
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Market source
Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- TradingKey
Novartis AG stock (CH0012005267): Immunology data at EULAR 2026 in focus for Swiss pharma group
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- ad-hoc-news.de
Novartis AG stock (CH0012005267): Spin-off, oncology focus and pipeline updates in the spotlight
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- ad-hoc-news.de
Novartis AG stock (CH0012005267): pipeline progress and steady demand keep pharma giant in focus
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 24 May 2026 07:00
- Source
- ad-hoc-news.de
Novartis stock (CH0012005267): U.S. drug pipeline and recent catalyst watch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- ad-hoc-news.de
Novartis (SWX:NOVN) Valuation Check After New Pluvicto PSMAddition Study Data And Regulatory Filings
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 19 May 2026 07:00
- Source
- Market source
Novartis AG stock (CH0012005267): dividend profile and pipeline focus move into the spotlight
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 16 May 2026 07:00
- Source
- ad-hoc-news.de
Novartis stock (CH0012005267): Q1 2026 earnings show blockbuster growth amid patent headwinds
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- ad-hoc-news.de
Novartis AG stock (CH0012005267): Mixed Q1 2026 results across pharma peers highlight sector dynamic
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- ad-hoc-news.de
Novartis AG stock (CH0012005267): Global pharma leader navigates patent cliffs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong 1-Year Share Price Run?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 May 2026 07:00
- Source
- Market source
Novartis AG stock (CH0012005267): Q1 2026 results miss EPS consensus as revenue dips slightly year?o
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- ad-hoc-news.de
Is It Too Late To Consider Novartis (SWX:NOVN) After Its 3 Year 41.9% Rise?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- simplywall.st
Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 May 2026 07:00
- Source
- Market source
Novartis AG (NVS) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 83/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- GuruFocus
Is It Too Late To Consider Novartis (SWX:NOVN) After Its 30% One-Year Rally?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Apr 2026 07:00
- Source
- Market source
Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Market source
Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Feb 2026 08:00
- Source
- The Economic Times